• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰老和阿尔茨海默病中大脑铁及铁调节蛋白的区域分布

Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease.

作者信息

Connor J R, Snyder B S, Beard J L, Fine R E, Mufson E J

机构信息

Department of Neuroscience and Anatomy, Pennsylvania State University College of Medicine, M.S. Hershey Medical Center, Hershey 17033.

出版信息

J Neurosci Res. 1992 Feb;31(2):327-35. doi: 10.1002/jnr.490310214.

DOI:10.1002/jnr.490310214
PMID:1573683
Abstract

It is well established that iron, which is of considerable importance for normal neurological function, is highly regulated in all organ systems. However, until recently, iron regulation in the nervous system has received little attention. This study quantitatively compares the levels of the major iron-regulatory proteins, transferrin and ferritin, and iron itself in three cerebral cortical regions of the human brain from material collected at autopsy. Three groups were studied: 1) normal adult (under 65 yr of age), 2) aged (greater than 65), and 3) Alzheimer's disease. Normally, transferrin is more abundant in white matter than in gray matter. Ferritin is approximately 10x more abundant than transferrin throughout the brain regions examined and is evenly distributed, as is iron, in the gray and white matter. In Alzheimer's disease transferrin is consistently decreased particularly in the white matter of the various cerebral cortical regions examined whereas the iron and ferritin changes are inconsistent. The observations in this study are consistent with our general hypothesis that iron homeostasis is disrupted in the aging brain and the alterations in iron-regulatory proteins are exacerbated in Alzheimer's disease. The decrease in transferrin levels could indicate a decreased mobility and subsequent utilization of iron in the brain. Such a decrease in iron availability could play a significant role in neuronal degeneration and increased peroxidative damage known to occur in Alzheimer's disease.

摘要

铁对正常神经功能至关重要,且在所有器官系统中受到高度调节,这一点已得到充分证实。然而,直到最近,神经系统中的铁调节才受到很少关注。本研究从尸检收集的材料中,定量比较了人类大脑三个脑皮质区域中主要铁调节蛋白、转铁蛋白和铁蛋白以及铁本身的水平。研究了三组对象:1)正常成年人(65岁以下),2)老年人(65岁以上),3)阿尔茨海默病患者。正常情况下,转铁蛋白在白质中比在灰质中更丰富。在整个检查的脑区中,铁蛋白比转铁蛋白大约丰富10倍,并且与铁一样,在灰质和白质中均匀分布。在阿尔茨海默病中,转铁蛋白持续减少,特别是在所检查的各个脑皮质区域的白质中,而铁和铁蛋白的变化则不一致。本研究中的观察结果与我们的一般假设一致,即衰老大脑中铁稳态被破坏,并且在阿尔茨海默病中铁调节蛋白的改变会加剧。转铁蛋白水平的降低可能表明大脑中铁的流动性降低以及随后的利用率降低。铁可用性的这种降低可能在阿尔茨海默病中已知发生的神经元变性和过氧化损伤增加中起重要作用。

相似文献

1
Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease.衰老和阿尔茨海默病中大脑铁及铁调节蛋白的区域分布
J Neurosci Res. 1992 Feb;31(2):327-35. doi: 10.1002/jnr.490310214.
2
Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains.转铁蛋白、铁蛋白和铁在正常及老年人类大脑中的细胞分布。
J Neurosci Res. 1990 Dec;27(4):595-611. doi: 10.1002/jnr.490270421.
3
A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains.阿尔茨海默病脑中铁、转铁蛋白和铁蛋白的组织化学研究。
J Neurosci Res. 1992 Jan;31(1):75-83. doi: 10.1002/jnr.490310111.
4
Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains.正常大脑与阿尔茨海默病大脑中铁调节蛋白与其铁反应元件之间相互作用的改变。
Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):761-76.
5
Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain.成年和老年大鼠大脑特定区域的铁蛋白、转铁蛋白及铁含量
J Comp Neurol. 1993 Dec 1;338(1):97-113. doi: 10.1002/cne.903380108.
6
MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.阿尔茨海默病和亨廷顿病中基底节铁蛋白铁及神经毒性的磁共振成像评估
Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):821-33.
7
Brain iron homeostasis.脑铁稳态
Dan Med Bull. 2002 Nov;49(4):279-301.
8
Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity.衰老大脑和阿尔茨海默病大脑中的小胶质细胞营养不良与铁蛋白免疫反应性有关。
Glia. 2008 Aug 1;56(10):1048-60. doi: 10.1002/glia.20678.
9
Regulation of the profile of iron-management proteins in brain microvasculature.脑微血管中铁管理蛋白谱的调控。
J Cereb Blood Flow Metab. 2004 Jan;24(1):67-74. doi: 10.1097/01.WCB.0000095800.98378.03.
10
Isoforms of ferritin have a specific cellular distribution in the brain.铁蛋白的异构体在大脑中具有特定的细胞分布。
J Neurosci Res. 1994 Mar 1;37(4):461-5. doi: 10.1002/jnr.490370405.

引用本文的文献

1
Uric Acid, the End-Product of Purine Metabolism, Mitigates Tau-Related Abnormalities: Comparison with DOT, a Non-Antibiotic Oxytetracycline Derivative.尿酸,嘌呤代谢的终产物,可减轻与tau相关的异常:与非抗生素土霉素衍生物DOT的比较。
Biomolecules. 2025 Jun 28;15(7):941. doi: 10.3390/biom15070941.
2
Ferroptosis and Iron Homeostasis: Molecular Mechanisms and Neurodegenerative Disease Implications.铁死亡与铁稳态:分子机制及对神经退行性疾病的影响
Antioxidants (Basel). 2025 Apr 28;14(5):527. doi: 10.3390/antiox14050527.
3
The role of the components of PM in the incidence of Alzheimer's disease and related disorders.
颗粒物成分在阿尔茨海默病及相关疾病发病中的作用。
Environ Int. 2025 Jun;200:109539. doi: 10.1016/j.envint.2025.109539. Epub 2025 May 18.
4
Cognitive Performance in Relation to Systemic and Brain Iron at Perimenopause.围绝经期与全身及脑铁相关的认知表现。
Nutrients. 2025 Feb 20;17(5):745. doi: 10.3390/nu17050745.
5
Carbon ion stimulation therapy reverses iron deposits and microglia driven neuroinflammation and induces cognitive improvement in an Alzheimer's disease mouse model.碳离子刺激疗法可逆转铁沉积和小胶质细胞驱动的神经炎症,并在阿尔茨海默病小鼠模型中诱导认知改善。
Sci Rep. 2025 Mar 7;15(1):7938. doi: 10.1038/s41598-025-91689-3.
6
Role of iron in brain development, aging, and neurodegenerative diseases.铁在大脑发育、衰老及神经退行性疾病中的作用。
Ann Med. 2025 Dec;57(1):2472871. doi: 10.1080/07853890.2025.2472871. Epub 2025 Mar 4.
7
Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review.BPC 157肽的多功能性及其可能的医学应用——文献与专利综述
Pharmaceuticals (Basel). 2025 Jan 30;18(2):185. doi: 10.3390/ph18020185.
8
Loss of calcium/calmodulin-dependent protein kinase kinase 2, transferrin, and transferrin receptor proteins in the temporal cortex of Alzheimer's patients postmortem is associated with abnormal iron homeostasis: implications for patient survival.阿尔茨海默病患者死后颞叶皮质中钙/钙调蛋白依赖性蛋白激酶激酶2、转铁蛋白和转铁蛋白受体蛋白的缺失与铁稳态异常有关:对患者生存的影响。
Front Cell Dev Biol. 2024 Nov 28;12:1469751. doi: 10.3389/fcell.2024.1469751. eCollection 2024.
9
Alterations in zinc, copper, and iron levels in the retina and brain of Alzheimer's disease patients and the APP/PS1 mouse model.阿尔茨海默病患者及APP/PS1小鼠模型视网膜和大脑中锌、铜和铁水平的变化。
Metallomics. 2024 Dec 2;16(12). doi: 10.1093/mtomcs/mfae053.
10
Postencephalitic Parkinsonism: Unique Pathological and Clinical Features-Preliminary Data.脑炎后帕金森病:独特的病理和临床特征——初步数据。
Cells. 2024 Sep 10;13(18):1511. doi: 10.3390/cells13181511.